DUBLIN, October 13, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Stem Cell Assay Market by Type (Viability, Differentiation, Cell Identification), Kit (Mesenchymal, IPSCS, Hematopoietic), Product (Flow Cytometer, Detection Kit), Application (Regenerative Medicines, Drug Development), End User - Forecast to 2021" report to their offering.
The global stem cell assay market is expected to reach USD 1,363.3 Million by 2021 from USD 536.6 Million in 2016, at a CAGR of 20.5% during the forecast period
Market growth can be attributed to the high prevalence of chronic diseases, increasing investment in research related activities, and technological advancements. However, stringent regulatory policies and high cost of stem cell based therapies are major factors restraining the growth of this market.
The global stem cell assay market has been segmented on the basis of type of assay, kit, detection, instrument, application, end-user, and region. On the basis of type of assay, the global market is segmented into viability/cytotoxicity, isolation & purification, cell identification, proliferation, differentiation, function and apoptosis. The viability/cytotoxicity segment is expected to be the largest and fastest-growing segment of the global market in 2016.; whereas, the isolation & purification segment is expected to grow at the highest CAGR during the forecast period.
Stem Cell Assay Market
North America dominates the global market in 2016, owing to the increasing incidence and prevalence of chronic diseases and increasing patient pool in North American countries. However, the RoW region is expected to witness the highest CAGR during the forecast period. The high growth in this segment is centered in Latin America, the Middle East, and Africa owing to the increased adoption of stem cell based therapies in these regions.
The major players in the stem cell assay market are include GE Healthcare (U.K.), Promega Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Cell Biolabs, Inc. (U.S.), Hemogenix Inc. (U.S.), STEMCELL Technologies Inc. (CA), Bio-Rad Laboratories, Inc. (U.S.), Bio-Techne Corporation (U.S.), and Cellular Dynamics International, Inc. (U.S.).
For more information about this report visit http://www.researchandmarkets.com/research/3g9k66/stem_cell_assay
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/136-billion-stem-cell-assay-market-by-type-kit-product-application--end-users---forecasts-to-2021---research-and-markets-300344243.html
SOURCE Research and Markets